Literature DB >> 1008070

Candida peritonitis. Report of 22 cases and review of the English literature.

A S Bayer, M J Blumenkrantz, J Z Montgomerie, J E Galpin, J W Coburn, L B Guze.   

Abstract

Thirty-one patients with Candida isolated from peritoneal fluid were examined. Twenty-two were considered to have Candida peritonitis. The data on these 22 patients, plus 12 additional patients described in the literature, were reviewed. This infection was observed as a complication of peritoneal dialysis, gastrointestinal surgery or perforation of an abdominal viscus. Recent antibiotic administration seemed to be an important predisposing factor. The disease usually remained localized intra-abdominally, although disseminated candidiasis was also noted in three cases. Clinically significant infection could be differentiated from peritoneal contamination with Candida by the presence and persistence of fever, peritoneal signs, peripheral leukocytosis, positive peritoneal cultures for Candida, abnormal films of the abdomen and purulent ascitic fluid. Surgical interventions and removal of infected peritoneal fluid were the cornerstones of therapy. Short-term, low-dose systemic and/or intraperitoneally administered amphotericin B appeared promising in the treatment of unremitting infection. Mortality in treated patients was low and was comparable to that in patients with bacterial peritonitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008070     DOI: 10.1016/0002-9343(76)90407-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Effective photodynamic therapy against microbial populations in human deep tissue abscess aspirates.

Authors:  Constantine G Haidaris; Thomas H Foster; David L Waldman; Edward J Mathes; Joanne McNamara; Timothy Curran
Journal:  Lasers Surg Med       Date:  2013-08-29       Impact factor: 4.025

3.  Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery.

Authors:  Yan-Shen Shan; Edgar D Sy; Shan-Tair Wang; Jenq-Chang Lee; Pin-Wen Lin
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

4.  Paecilomyces variotii in peritoneal dialysate.

Authors:  A Marzec; L G Heron; R C Pritchard; R H Butcher; H R Powell; A P Disney; F A Tosolini
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 5.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

6.  Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.

Authors:  A S Bayer; J E Edwards; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Estimations of serum arabinitol for diagnosing invasive candidosis.

Authors:  A G Deacon
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

9.  Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors: 
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

10.  Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

Authors:  J S Solomkin; A Flohr; R L Simmons
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.